J.-Th. Fischer

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 170 citations

Medicine, Hematology, Oncology +5

Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann et al. · Leukemia · 2003 · 81 citations

Pharmacy, Oncology, Pharmacotherapy +7

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Aloïs Gratwohl, Markus Pfirrmann, A. Zander et al. · Leukemia · 2015 · 55 citations · Full text

Medicine, Hematology, Cell Therapy +13

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia

Richard F. Schlenk, Ulrich Germing, Frank Hartmann et al. · Leukemia · 2005 · 42 citations

Medicine, Oncology, Pharmacology +15

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

W.-K. Hofmann, Arnold Ganser, G. Seipelt et al. · Annals of Hematology · 1999 · 35 citations

Medicine, Hematology, Pharmacotherapy +10